Get the Stockscreener App
161.88
2.40%
3.79
After Hours:
161.88
Natera Inc stock is traded at $161.88, with a volume of 2.81M.
It is up +2.40% in the last 24 hours and down -3.57% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$158.09
Open:
$154.68
24h Volume:
2.81M
Relative Volume:
2.29
Market Cap:
$21.37B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-33.59
EPS:
-4.82
Net Cash Flow:
$-43.68M
1W Performance:
-2.80%
1M Performance:
-3.57%
6M Performance:
+51.01%
1Y Performance:
+182.61%
1-Day Range:
$154.01
$163.05
1-Week Range:
$153.53
$172.80
52-Week Range:
$58.21
$175.63
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
161.88 | 21.37B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Principal Financial Group Inc. Has $128.54 Million Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera co-founder Sheena Jonathan sells $953,337 in stock By Investing.com - Investing.com South Africa
Natera co-founder Sheena Jonathan sells $953,337 in stock - Investing.com
Stanley Druckenmiller's Top Holding Has Outperformed Its Sector By 252% - Benzinga
Natera expands lawsuit against NeoGenomics over RaDaR test By Investing.com - Investing.com Canada
Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy? - Zacks Investment Research
Natera expands lawsuit against NeoGenomics over RaDaR test - Investing.com
Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics - Business Wire
What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller? - Insider Monkey
Wilmington Savings Fund Society FSB Acquires Shares of 3,033 Natera, Inc. (NASDAQ:NTRA) - MarketBeat
TD Cowen reiterates Buy on Natera shares, sees positive outlook despite new competition By Investing.com - Investing.com South Africa
TD Cowen reiterates Buy on Natera shares, sees positive outlook despite new competition - Investing.com India
Natera, Inc. (NASDAQ:NTRA) Shares Sold by National Bank of Canada FI - MarketBeat
7,319 Shares in Natera, Inc. (NASDAQ:NTRA) Bought by Orion Portfolio Solutions LLC - MarketBeat
Franklin Resources Inc. Purchases 328,375 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Barclays PLC Trims Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Geode Capital Management LLC Has $265.75 Million Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera executive chairman sells $26.5 million in stock By Investing.com - Investing.com South Africa
Natera executive chairman sells $26.5 million in stock - Investing.com
Market Whales and Their Recent Bets on NTRA Options - Benzinga
Natera (NASDAQ:NTRA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer - Yahoo! Voices
Natera begins subject enrolment in colon cancer detection test trial - Yahoo! Voices
Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer - Business Wire
TCW Group Inc. Has $4.47 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
9,984 Shares in Natera, Inc. (NASDAQ:NTRA) Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Insider Sell: Rowan Chapman Sells 1,767 Shares of Natera Inc (NT - GuruFocus.com
Natera's president of clinical diagnostics sells $809k in stock By Investing.com - Investing.com South Africa
Natera director Chapman Rowan E sells $300k in stock - Investing.com
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal - The Eastern Progress Online
Labcorp Accuses Ex-Sales Exec Of Stealing Customers - Law360
State Street Corp Decreases Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
DNA Testing Market Report: Comprehensive Insights and Key - openPR
Gordian Capital Singapore Pte Ltd Has $1.04 Million Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment - Business Wire
Worldquant Millennium Advisors LLC Takes $518,000 Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Don't Ignore The Insider Selling In Natera - Simply Wall St
Wellington Management Group LLP Buys 1,883,481 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera Inc. amends agreement with Executive Chairman By Investing.com - Investing.com Australia
Natera Inc. amends agreement with Executive Chairman - Investing.com India
Rep. Josh Gottheimer Purchases Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Benjamin Edwards Inc. Grows Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
BNP Paribas Financial Markets Decreases Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera Aligns Executive Chairman’s Pay with Performance - TipRanks
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Cinctive Capital Management LP - MarketBeat
Natera Stock Soars to All-Time High, Reaching $172.49 By Investing.com - Investing.com Nigeria
Roelof Botha sells $14.79 million in Natera stock - Investing.com India
Roelof Botha sells $14.79 million in Natera stock By Investing.com - Investing.com Nigeria
Natera Stock Soars to All-Time High, Reaching $172.49 - Investing.com India
Bamco Inc. NY Sells 6,000 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Purchased by The Manufacturers Life Insurance Company - MarketBeat
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Natera Inc Stock (NTRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | CO-FOUNDER |
Dec 18 '24 |
Sale |
167.27 |
2,700 |
451,625 |
257,072 |
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):